Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605679 · ClinicalTrials.gov registry record · NA
Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients
A NA study of Kidney Failure, sponsored by Loma Linda University.
- Active
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT04605679: Active NA study of Kidney Failure, sponsored by Loma Linda University.
NCT04605679 is a NA study of Kidney Failure that is active but no longer recruiting, run by Loma Linda University. The registered enrollment target is 31 participants, below the 586-participant average among 18 other Kidney Failure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04605679, a NA study of Kidney Failure, is active but no longer recruiting, sponsored by Loma Linda University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the efficacy and safety of transplanting HCV positive kidney allografts to HCV sero-negative patients who are on the waiting list.
Primary Outcome
Will track subjects post transplant for 12 months
Conditions Studied
Interventions
- PROCEDURE Kidney Transplantation
Study Locations (1)
California
- Loma Linda University Health-Transplant Institute - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-05-06 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT04605679 still lists
NCT04605679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 586-participant average among 18 other Kidney Failure trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Kidney Failure appearing as the primary indexed condition, and to 1 intervention - of which Kidney Transplantation is the first listed.
NCT04605679 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04605679 about?
NCT04605679 is a clinical study titled "Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients". To determine the efficacy and safety of transplanting HCV positive kidney allografts to HCV sero-negative patients who are on the waiting list.
What is the current status of trial NCT04605679?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2020-05-06. Estimated completion is 2026-12.
What conditions does trial NCT04605679 study?
This clinical trial studies the following conditions: Kidney Failure.
What interventions are being tested in trial NCT04605679?
The interventions under investigation include: Kidney Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT04605679?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04605679 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04605679's enrollment target sits among peer trials
31 13th of 18 higher than 6 of 18 other Kidney Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
RECRUITING · NA
-
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
RECRUITING · NA
-
Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media
ACTIVE NOT RECRUITING · NA
-
Healthy.io Method Comparison & User Performance Study
COMPLETED · NA
-
Acute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis Patients
COMPLETED · NA
-
Tolerance Through Mixed Chimerism (Sip-Tego)
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI